🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalItaly AIFA reimbursement — anyone have experience? Page 7

Italy AIFA reimbursement — anyone have experience?

pete_nash Fri, Jul 11, 2025 at 10:03 PM 50 replies 2,366 viewsPage 7 of 10
TomFromTexas
Member
645
2,890
May 2024
Austin, TX
Sep 28, 2025 at 10:30 AM#31
TirzTom said:
One habit that pays for itself: post the method alongside the number.

This is exactly what I could not find anywhere else.

20 20PharmD_Rodriguez, julia.endo, JessicaM_2024 and 17 others
Reply Quote Save Share Report
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Oct 4, 2025 at 10:47 AM#32

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

19 19TinaHashiRN, robert_kc, dan_philly and 16 others
Reply Quote Save Share Report
TomTeleRx
Member
189
678
Feb 2025
Delaware
Oct 10, 2025 at 11:08 AM#33
EndoResFellow said:
The useful move here is to separate what is established from what is widely repeated.

Adding a me-too, because a thread of one person's experience is not much use. I had assumed I was the exception until I read this.

18 18LibrarianMeg, bri_stats, pete_manc_UK and 15 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
SaraMom3
Member
456
2,345
Aug 2024
Ohio
Oct 16, 2025 at 11:32 AM#34
EndoResFellow said:
The useful move here is to separate what is established from what is widely repeated.

There is a second half to this that has not been said yet. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

17 17CanadaChris, ZaraB_AL, JakeSmashed95 and 14 others
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Oct 22, 2025 at 12:00 PM#35

One concrete data point for the thread. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

16 16JessicaM_2024, TomFromTexas, mike.trainer_LA and 13 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register